Evidence map›Paper›PMID 18555826›Full record

ArticleMetabolism: clinical and experimental2008

Elevated lipid peroxidation and DNA oxidation in nerve from diabetic rats: effects of aldose reductase inhibition, insulin, and neurotrophic factors.

Joice M Cunha, Corinne G Jolivalt, Khara M Ramos, Joshua A Gregory, Nigel A Calcutt, Andrew P Mizisin

Open access · greenAbstract read
In one paragraph

Article in Metabolism: clinical and experimental, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Neuroprotective effects ofExperimental and therapeutic medicine · 2015
    Article
  5. Review
  6. Peripheral neuropathy in rats exposed to dichloroacetate.Journal of neuropathology and experimental neurology · 2009
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Joice M CunhaDepartment of Pathology, University of California San Diego, La Jolla, CA 92093-0612, USA.
Corinne G Jolivalt
Khara M Ramos
Joshua A Gregory
Nigel A Calcutt
Andrew P Mizisin
University of California, San Diego · US

Funding

Mechanisms of Spinally-Mediated Hyperalgesia in DiabetesR01DK057629 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CALCUTT, NIGEL A. · 2003 to 2011
$2.4M
Oxidative Stress and Nerve Pathology in DiabetesR01DK078373 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MIZISIN, ANDREW P · 2006 to 2008
$806k
NIDDK NIH HHS DK057629NIDDK NIH HHS DK078374NIDDK NIH HHS R01 DK057629NIDDK NIH HHS R01 DK078373PHS HHS HHSN267200612889C
6 · The paper itself

Abstract

We investigated the effect of treatment with an aldose reductase inhibitor, insulin, or select neurotrophic factors on the generation of oxidative damage in peripheral nerve. Rats were either treated with streptozotocin to induce insulin-deficient diabetes or fed with a diet containing 40% d-galactose to promote hexose metabolism by aldose reductase. Initial time course studies showed that lipid peroxidation and DNA oxidation were significantly elevated in sciatic nerve after 1 week or 2 weeks of streptozotocin-induced diabetes, respectively, and that both remained elevated after 12 weeks of diabetes. The increase in nerve lipid peroxidation was completely prevented or reversed by treatment with the aldose reductase inhibitor, ICI 222155, or by insulin, but not by the neurotrophic factors, prosaptide TX14(A) or neurotrophin-3. The increase in nerve DNA oxidation was significantly prevented by insulin treatment. In contrast, up to 16 weeks of galactose feeding did not alter nerve lipid peroxidation or protein oxidation, despite evidence of ongoing nerve conduction deficits. These observations demonstrate that nerve oxidative damage develops early after the onset of insulin-deficient diabetes and that it is not induced by increased hexose metabolism by aldose reductase per se, but rather is a downstream consequence of flux through this enzyme. Furthermore, the beneficial effect of prosaptide TX14(A) and neurotrophin-3 on nerve function and structure in diabetic rats is not due to amelioration of increased lipid peroxidation.

Indexed as

Aldehyde ReductaseAnimalsBlood GlucoseBody WeightDiabetes Mellitus, ExperimentalDiabetic NeuropathiesDNAEnzyme InhibitorsFemaleGalactitolGalactoseHydrazonesHypoglycemic AgentsInsulinLipid PeroxidationMalondialdehyde2,4-dinitrophenylhydrazoneAldehyde ReductaseBlood GlucoseDNAEnzyme InhibitorsGalactitolGalactoseHydrazonesHypoglycemic AgentsICI 222155InsulinMalondialdehydeNerve Growth FactorsNitroparaffinsSulfones

Identifiers

PMID18555826
PMCPMC2518323
OpenAlexW2071474384

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.